Hydrea — Hydroxyurea 500 mg, 30 pcs, Everest
100% original product

Hydrea Capsules — Hydroxyurea 500 mg (30 Caps) Everest

4068 5051 -19%

Hydrea 500 mg (Hydroxyurea / Hydroxycarbamide) is a widely used antimetabolite antineoplastic agent. It works by inhibiting DNA synthesis in dividing cells, making it essential for managing myeloproliferative disorders.

Manufacturer: Everest Pharmaceuticals (Bangladesh). This medication is primarily used to reduce high platelet and white blood cell counts to prevent complications like thrombosis.

Key Features:

  • Blood Count Control: Rapidly lowers dangerous levels of blood cells in leukemia and related disorders.
  • Versatility: Effective for chronic blood cancers and as an adjunct to radiation therapy for certain solid tumors.
  • Oral Therapy: Convenient capsule form for outpatient management.

Prescribed by hematologists/oncologists for adult patients with:

  • 🔹 Chronic Myeloid Leukemia (CML): For resistant chronic phase or palliative control.
  • 🔹 Essential Thrombocythemia: To lower platelet counts and reduce thrombosis risk.
  • 🔹 Polycythemia Vera: To control red blood cell mass and blood viscosity.
  • 🔹 Head and Neck Cancer / Cervical Cancer: Used concurrently with radiation therapy to enhance its effectiveness (radiosensitizer).

Sales Unit: Bottle containing 30 capsules (500 mg strength).

⚠️ APPLICATION INSTRUCTIONS:

  • Dosing: Strictly individualized based on the patient's actual or ideal body weight (typically 20–30 mg/kg daily).
  • Administration: Swallow the capsule whole with water. Do not chew. Can be taken as a single dose or divided doses.
  • Safety: The powder inside is cytotoxic. Do not open capsules. If powder spills, wipe up with a damp cloth immediately; avoid inhaling.
  • Monitoring: Weekly complete blood counts (CBC) are mandatory during the initiation of therapy.

  • Pregnancy & Breastfeeding: Strictly contraindicated due to risk of birth defects.
  • Severe bone marrow depression: Leukopenia (< 2.5×10⁹/L) or Thrombocytopenia (< 100×10⁹/L).
  • Severe anemia (must be corrected before starting treatment).
  • Hypersensitivity to Hydroxyurea.

Bone marrow suppression is the dose-limiting toxicity. Potential side effects:

  • 📉 Hematologic: Leukopenia (infection risk), thrombocytopenia (bleeding risk), and anemia.
  • 🤢 Gastrointestinal: Nausea, vomiting, stomatitis (mouth sores).
  • 🧬 Dermatologic: Skin dryness, hyperpigmentation (darkening), and rarely skin ulcers with long-term use.
  • 🦠 General: Fever, chills.

Notice. The information on this page is for reference only and does not replace medical consultation. Always consult a healthcare professional and read the manufacturer's instructions before using any medicine. Self-medication may be dangerous. Information updated: 18.05.2026

Active ingredient
Dosage form Capsules
Capsules per pack 30
100% original product
Delivery across Ukraine
Customer reviews

What Customers Say

No reviews yet

Your review can be the first!

Unifarm

Unifarm app

Safari → Share → Add to Home Screen Firefox: menu ⋮ → Install or Add to Home screen. If missing, open the site in Chrome. Chrome: menu ⋮ → Install app or Add to Home screen.

Contact us

Choose a convenient way to contact

We work daily from 9:00 to 20:00